The Technical Analyst
Select Language :
Nephros Inc [NEPH]

Exchange: NASDAQ Sector: Healthcare Industry: Medical Instruments & Supplies

Nephros Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Nephros Inc is listed at the  Exchange

-6.01% $2.19

America/New_York / 28 mar 2024 @ 16:00


FUNDAMENTALS
MarketCap: 23.09 mill
EPS: -0.150
P/E: -14.60
Earnings Date: May 07, 2024
SharesOutstanding: 10.54 mill
Avg Daily Volume: 0.0206 mill
RATING 2024-03-28
B+
Neutral
RATINGS
Rating CashFlow: Buy
Return On Equity: Sell
Return On Asset: Neutral
DE: Buy
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -14.60 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.44x
Company: PE -14.60 | industry: PE 33.06
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 1.949 - 2.43

( +/- 11.00%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-13 Wexford Capital Lp Sell 91 463 Common Stock
2024-03-13 Amron Arthur H Buy 91 463 Common stock
2024-03-12 Amron Arthur H Buy 7 000 Common stock
2023-12-13 Spandow Oliver J. Buy 14 294 Common Stock
2023-12-13 Lask Alisa Buy 9 291 Common Stock
INSIDER POWER
4.17
Last 97 transactions
Buy: 1 485 864 | Sell: 673 582

Forecast: 16:00 - $2.23

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $2.23
Forecast 2: 16:00 - $2.23
Forecast 3: 16:00 - $2.23
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $2.19 (-6.01% )
Volume 0.0032 mill
Avg. Vol. 0.0206 mill
% of Avg. Vol 15.38 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Nephros Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Nephros Inc

RSI

Last 10 Buy & Sell Signals For NEPH

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Nephros Inc

NEPH

Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it offers water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and AETHER brands for the food service, hospitality, convenience store, and health care markets. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Last 10 Buy Signals

Date Signal @
UNIUSDMar 28 - 16:17$12.73
QTUMUSDMar 28 - 16:15$4.72
HUNTUSDMar 28 - 16:150.512
OPUSDMar 28 - 16:133.70
OKTUSDMar 28 - 16:1419.22
ETHUSDMar 28 - 16:16$3 554.72
WETHUSDMar 28 - 16:093 566.28
SETHUSDMar 28 - 16:133 559.47
DOGEUSDMar 28 - 16:13$0.221
NXMUSDMar 28 - 16:1173.51

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.